Madison Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.8M Hold
242,132
0.08% 150
2025
Q4
$6.03M Hold
242,132
0.07% 158
2025
Q3
$6.17M Buy
242,132
+40,646
+20% +$1M 0.07% 155
2025
Q2
$4.88M Hold
201,486
0.05% 172
2025
Q1
$5.11M Sell
201,486
-543
-0.3% -$14.2K 0.06% 163
2024
Q4
$5.36M Sell
202,029
-1,179
-0.6% -$32K 0.06% 162
2024
Q3
$5.88M Sell
203,208
-1,221
-0.6% -$35.6K 0.07% 159
2024
Q2
$5.72M Sell
204,429
-7,790
-4% -$214K 0.07% 162
2024
Q1
$5.89M Sell
212,219
-382,682
-64% -$10.6M 0.07% 162
2023
Q4
$17.1M Sell
594,901
-64,452
-10% -$1.95M 0.23% 107
2023
Q3
$21.9M Sell
659,353
-186,566
-22% -$6.6M 0.32% 91
2023
Q2
$31M Buy
845,919
+235,813
+39% +$9.18M 0.45% 76
2023
Q1
$24.9M Sell
610,106
-42,265
-6% -$1.83M 0.38% 87
2022
Q4
$33.4M Sell
652,371
-35,159
-5% -$1.69M 0.52% 65
2022
Q3
$30.1M Sell
687,530
-6,458
-0.9% -$314K 0.51% 72
2022
Q2
$36.4M Buy
693,988
+110,827
+19% +$5.65M 0.57% 66
2022
Q1
$30.2M Sell
583,161
-227,645
-28% -$11.8M 0.43% 86
2021
Q4
$47.9M Sell
810,806
-33,061
-4% -$1.64M 0.63% 62
2021
Q3
$36.3M Buy
843,867
+364,051
+76% +$16.1M 0.5% 76
2021
Q2
$18.8M Buy
479,816
+2,750
+0.6% +$107K 0.25% 110
2021
Q1
$17.3M Sell
477,066
-18,740
-4% -$665K 0.24% 111
2020
Q4
$18.3M Sell
495,806
-20,403
-4% -$748K 0.27% 103
2020
Q3
$18M Buy
516,209
+3,482
+0.7% +$122K 0.3% 97
2020
Q2
$15.9M Buy
512,727
+63,379
+14% +$2.15M 0.28% 100
2020
Q1
$13.9M Buy
449,348
+11,895
+3% +$405K 0.29% 99
2019
Q4
$16.3M Buy
+437,453
New +$15.6M 0.25% 106

Other funds holding PFE

Madison Asset Management's PFE Position: Q1 2026 in Review

Madison Asset Management held its Pfizer (PFE) position steady in Q1 2026 at 242,132 shares worth $6.8M. The position accounts for 0.08% of the portfolio, ranked #150.

Madison Asset Management first reported a position in PFE in Q4 2019 and has held it in 26 quarters since. The position peaked at $47.9M in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Madison Asset Management held 242,132 shares of Pfizer worth $6.8M as of Q1 2026.
  • Madison Asset Management left its Pfizer share count unchanged in Q1 2026.
  • Pfizer made up 0.08% of Madison Asset Management's portfolio in Q1 2026, its #150 holding.
  • Madison Asset Management first reported a position in Pfizer in Q4 2019 and has held it in 26 quarters since.
  • Madison Asset Management's Pfizer position peaked at $47.9M in Q4 2021.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Madison Asset Management's 13F filing for Q1 2026, filed 7 May 2026.